AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
New Home-Administered Treatment for ... Help Kids With Eating Disorders Apr. 5, 2023 — Whether you're afraid of dogs, needles or enclosed spaces, one of the most effective interventions for ...